Mintek Pacemaker LV-T Manuel d'utilisateur Page 34

  • Télécharger
  • Ajouter à mon manuel
  • Imprimer
  • Page
    / 172
  • Table des matières
  • MARQUE LIVRES
  • Noté. / 5. Basé sur avis des utilisateurs
Vue de la page 33
26 Stratos LV/LV-T Technical Manual
Table 2: Atrial Fibrillation Demographics at Enrollment
Characteristic Group 1 Group 2 Group 3 P-value*
Rate Control
Medication,
Reasons for
Discontinuation
Ineffective
Not tolerated
Other
N=17
10 (58.8%)
8 (47.1%)
1 (5.9%)
N=20
13 (65.0%)
7 (35.0%)
2 (10.0%)
N=12
9 (75.0%)
3 (25.0%)
0 (0.0%)
0.558
0.760
0.800
Rhythm Control
Medication,
Reasons for
Discontinuation
Ineffective
Not tolerated
Other
N=22
17 (77.3%)
6 (27.3%)
1 (4.5%)
N=25
20 (80.0%)
7 (28.0%)
1 (4.0%)
N=13
8 (61.5%)
6 (46.2%)
2 (15.4%)
0.759
0.530
0.430
Cardioversion
History
Successful prior
electrical
cardioversion
Transthoracic
Transvenous
Unsuccessful prior
electrical
cardioversion
Transthoracic
Transvenous
No electrical
cardioversion
attempted
Successful prior
pharmacological
cardioversion
Unsuccessful prior
pharmacological
cardioversion
No pharmacological
cardioversion
attempted
N=42
13 (31.0%)
13 (100.0%)
0 (0.0%)
15 (35.7%)
15 (100.0%)
0 (0.0%)
17 (40.5%)
5 (11.9%)
8 (19.0%)
23 (54.8%)
N=49
16 (32.7%)
15 (93.8%)
1 (6.3%)
14 (28.6%)
14 (93.3%)
2 (13.3%)
20 (40.8%)
3 (6.1%)
11 (22.4%)
29 (59.2%)
N=25
10 (40.0%)
10 (100.0%)
0 (0.0%)
7 (28.0%)
7 (100.0%)
0 (0.0%)
9 (36.0%)
3 (12.0%)
7 (28.0%)
15 (60.0%)
0.760
0.808
0.680
0.741
0.936
0.547
0.678
0.915
*Chi-Square test (2-sided)
Vue de la page 33
1 2 ... 29 30 31 32 33 34 35 36 37 38 39 ... 171 172

Commentaires sur ces manuels

Pas de commentaire